Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 26, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Participate in Upcoming BTIG Investment Conference

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will be...
July 14, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at Controlled Release Society 2022

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared two posters that were presented at the...
July 07, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform

SAN DIEGO, July 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced topline results from its recently...
June 22, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference

SAN DIEGO, June 22, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of an abstract presenting...
May 31, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis

SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a presentation delivered during Digestive...
May 25, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022

Patient Data Suggests Multiple Additional Inflammatory Pathways, Supporting Potential Need for Combination Therapy for Ulcerative Colitis Patient Data Establishes Proof of Concept for Microbiome...
May 19, 2022 09:00 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform

SAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced a new patent related to its Drug Delivery...
May 16, 2022 16:30 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company’s management team will be...
May 10, 2022 16:01 ET | Source: Biora Therapeutics, Inc.

Biora Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

Completed transformation with the launch of Biora Therapeutics to reflect the company’s focus on oral therapeutic solutions Successfully transferred its single-molecule detection platform with...
May 05, 2022 06:30 ET | Source: Progenity, Inc.

Progenity Announces Successful Transfer of Liquid Biopsy Technologies

SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG) today announced it has completed the divesture of a collection of novel, discovery-stage biochemical and bioinformatics...